Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 01/16/2026 | CALL | $2.50 | 5,994 | +161 | +2.76% |
| 01/16/2026 | PUT | $2.50 | 1,490 | +56 | +3.91% |
| 01/16/2026 | CALL | $5.00 | 5,386 | +26 | +0.49% |
| 04/17/2026 | PUT | $5.00 | 185 | +1 | +0.54% |
| 12/19/2025 | CALL | $2.50 | 19 | 0 | |
| 12/19/2025 | CALL | $5.00 | 53 | 0 | |
| 07/17/2026 | PUT | $2.50 | 110 | 0 | |
| 07/17/2026 | PUT | $5.00 | 0 | 0 | |
| 07/17/2026 | PUT | $7.50 | 0 | 0 | |
| 12/19/2025 | PUT | $5.00 | 18 | -1 | -5.26% |
| 04/17/2026 | CALL | $2.50 | 2,687 | -17 | -0.63% |
| 04/17/2026 | CALL | $5.00 | 2,157 | -30 | -1.37% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.65% | 2.15M | 1.16M |
| Vanguard Explorer Fund, Inc. | 1.33% | 1.73M | 935.62k |
| Vanguard Extended Market Index Fund | 0.76% | 985.66k | 532.35k |
| Fidelity Extended Market Index Fund | 0.28% | 367.07k | 198.25k |
| iShares Micro Cap ETF | 0.13% | 174.97k | 94.5k |
| Vanguard Variable Insurance Fund-Small Company Growth | 0.12% | 151.27k | 81.7k |
| Fidelity Total Market Index Fund | 0.09% | 118.33k | 63.91k |
| Delaware Group Equity Fds IV-Delaware Healthcare Fund | 0.08% | 100k | 54.01k |
| iShares Core S&P Total U.S. Stock Market ETF | 0.08% | 99.59k | 53.79k |
| Fidelity Series Total Market Index Fund | 0.07% | 88.53k | 47.81k |
Fortress Biotech Investigated by the Portnoy Law Firm
10/01 03:45 pm
GlobeNewswire Inc.
Read moreFortress Biotech and Cyprium Therapeutics Announce an Update on the NDA for CUTX-101
10/01 08:00 am
GlobeNewswire Inc.
Read moreFortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics
05/30 10:47 am
Benzinga
Read moreFortress Biotech to Participate in the H.C. Wainwright 1st Annual Royalty Company Virtual Conference
05/07 08:00 am
GlobeNewswire Inc.
Read moreMustang Bio Announces Closing of $8 Million Public Offering
02/10 09:00 am
GlobeNewswire Inc.
Read moreMustang Bio Announces Pricing of $8 Million Public Offering
02/06 08:00 am
Benzinga
Read moreMustang Bio Announces Pricing of $8 Million Public Offering
02/06 08:00 am
GlobeNewswire Inc.
Read moreFortress Biotech CEO buys $36.7k in preferred stock - Investing.com
07/10 08:41 am
Investing.com
Read moreGreenbrier, Fortress Biotech And 3 Stocks To Watch Heading Into Monday - Greenbrier Companies (NYSE:GBX) - Benzinga
07/08 03:10 am
Benzinga
Read moreCheckpoint Therapeutics Announces $12 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
07/02 08:00 am
GlobeNewswire Inc.
Read moreCheckpoint Therapeutics Announces Biologics License Application Resubmission for Cosibelimab
07/02 07:00 am
GlobeNewswire Inc.
Read moreCheckpoint Therapeutics Announces Alignment with FDA Enabling Upcoming Cosibelimab BLA Resubmission
06/24 07:30 am
GlobeNewswire Inc.
Read moreFortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase
05/16 08:00 am
GlobeNewswire Inc.
Read moreFortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
05/15 04:15 pm
GlobeNewswire Inc.
Read moreJourney Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase
05/15 04:01 pm
GlobeNewswire Inc.
Read moreAquaBounty Technologies, Inc. (AQB) Reports Q1 Loss, Misses Revenue Estimates
05/15 10:20 am
Zacks Investment Research
Read moreOvid Therapeutics (OVID) Reports Q1 Loss, Tops Revenue Estimates
05/14 09:10 am
Zacks Investment Research
Read moreJourney Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
05/13 04:01 pm
GlobeNewswire Inc.
Read moreCheckpoint Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
05/13 08:30 am
GlobeNewswire Inc.
Read moreCheckpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Updates
05/10 08:30 am
GlobeNewswire Inc.
Read moreAveanna Healthcare (AVAH) Reports Q1 Loss, Tops Revenue Estimates
05/09 07:40 am
Zacks Investment Research
Read moreJourney Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024
05/07 08:30 am
GlobeNewswire Inc.
Read moreJourney Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024
04/25 08:30 am
GlobeNewswire Inc.
Read moreFortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights
03/28 04:05 pm
GlobeNewswire Inc.
Read moreCheckpoint Therapeutics Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
03/22 08:30 am
GlobeNewswire Inc.
Read moreJourney Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
03/21 04:01 pm
GlobeNewswire Inc.
Read moreJourney Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea
03/18 08:30 am
GlobeNewswire Inc.
Read moreJourney Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024
03/15 08:30 am
GlobeNewswire Inc.
Read moreJourney Medical Corporation to Participate in the 36th Annual ROTH Conference
03/13 08:30 am
GlobeNewswire Inc.
Read moreFortress Biotech to Participate in 36th Annual ROTH Conference
03/12 08:30 am
GlobeNewswire Inc.
Read moreJourney Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting
03/11 08:30 am
GlobeNewswire Inc.
Read moreFortress Biotech and Cyprium Therapeutics Announce $4.1 Million Grant from NINDS to Further Development of AAV-ATP7A Gene Therapy for Menkes Disease
03/04 09:30 am
GlobeNewswire Inc.
Read moreAlzamend Neuro And 3 Other Stocks Under $3 Insiders Are Buying
01/10 09:09 am
Benzinga
Read moreJourney Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea
01/05 09:30 am
GlobeNewswire Inc.
Read moreFortress Biotech Announces Closing of $11 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
01/03 05:01 pm
GlobeNewswire Inc.
Read moreJourney Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million
01/02 05:05 pm
GlobeNewswire Inc.
Read moreFear & Greed Index Remains In 'Extreme Greed' Zone; S&P 500 Surges 24% In 2023
01/02 03:32 am
Benzinga
Read moreFortress Biotech Announces Pricing of $11 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
12/29 09:20 am
GlobeNewswire Inc.
Read moreCyprium Therapeutics, a Fortress Biotech Subsidiary Company, Completes Asset Transfer of CUTX-101 Copper Histidinate Product Candidate for Treatment of Menkes Disease, to Sentynl Therapeutics, a Wholly-owned Subsidiary of Zydus Lifesciences Ltd.
12/06 09:30 am
GlobeNewswire Inc.
Read moreJourney Medical Corporation Announces Successful Completion of Pre-NDA Meeting with the FDA for DFD-29 to Treat Rosacea
12/06 09:00 am
GlobeNewswire Inc.
Read moreRoth MKM Maintains Buy Rating for Fortress Biotech: Here's What You Need To Know
11/29 01:00 pm
Benzinga
Read moreBest Penny Stocks To Buy This Week? 4 To Watch Now
11/20 11:17 am
PennyStocks
Read more11 Top Penny Stocks To Buy Now According To Insiders
11/17 02:32 pm
PennyStocks
Read moreFortress Biotech Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
11/14 05:10 pm
GlobeNewswire Inc.
Read moreFortress Biotech Announces Closing of $10.0 Million Public Offering
11/14 05:01 pm
GlobeNewswire Inc.
Read more